Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides
about
Eurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTIONEfficient molecular mechanics simulations of the folding, orientation, and assembly of peptides in lipid bilayers using an implicit atomic solvation model.Molecular dynamics investigation of the influence of anionic and zwitterionic interfaces on antimicrobial peptides' structure: implications for peptide toxicity and activityEffects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infectionNovel synthetic antimicrobial peptides against Streptococcus mutans.Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance.Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions.Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus.A technology for developing synbodies with antibacterial activityClinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of Streptococcus mutans and prevention of demineralizationThe human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors.Bacterial killing mechanism of sheep myeloid antimicrobial peptide-18 (SMAP-18) and its Trp-substituted analog with improved cell selectivity and reduced mammalian cell toxicity.Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopyInduction of group A Streptococcus virulence by a human antimicrobial peptide.The roles of antimicrobial peptides in innate host defense.Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides.Site-specific orientation of an α-helical peptide ovispirin-1 from isotope-labeled SFG spectroscopyA cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.Descriptors for antimicrobial peptides.Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model.Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp.A generalized born implicit-membrane representation compared to experimental insertion free energies.Evaluating tilt angles of membrane-associated helices: comparison of computational and NMR techniques.Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide.SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes.The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.Probing Site-Specific Structural Information of Peptides at Model Membrane Interface In Situ.Sepsis and innate immunity.
P2860
Q27674703-87964374-2E30-4858-A329-40463D5337BAQ30155477-0BE5FE6C-8827-44D9-AB43-8779DC8C3FC4Q31023000-8F222049-E6E3-4AF4-97BC-9966067E806DQ33222432-FF49DA78-D599-458D-9A9A-FEE6F6A781B0Q33273497-BAC09112-512E-49E2-B522-EB0C0C1CD4FCQ33502861-E071FC3D-43DD-4465-8D13-64AE3D303BA3Q33815857-52DEB934-4C8F-40EF-9AAB-6F64116A21E5Q34064236-761CD1D8-65F6-4B4B-9928-2043430DE026Q34570999-7DD03B04-DF55-4F5E-9F80-5AA9FB3F7894Q34631788-91932056-10A7-4F1B-99D8-A3E56CD6C133Q34774620-676C17C5-CB21-4345-827B-32463DA7908EQ35039695-DEBD810F-6CDD-4E1E-8DAC-30776817434BQ35173769-6869CB79-6C4A-4FFB-B446-861EF68F98ACQ35269863-2F064067-7AEB-41AE-B890-F0FFA90644D9Q36954965-1D909691-6840-4D63-A4BC-7B8944D728FAQ37361213-09BFEE8C-6803-45CD-ADCA-331717E080FAQ37385746-A2665E03-0D1C-48B0-B1DA-1EAF2BAA484FQ37495342-DA444CBC-BC96-4A44-992B-D63F8AA18B32Q37866767-95A13ABF-D9B9-4340-8842-4F6A0DF17E80Q38014581-CBD3B137-A500-406E-B3A4-B955942637A5Q40345327-E7609340-49C7-4E58-9FCF-FFE5032860C4Q41973626-F103A8E2-3B4E-4B21-A9B9-FBF36337F080Q42037742-198ECADA-1D98-4DF6-9322-265097D92C3AQ42155185-FDC8652C-4A01-4556-9CF6-9120735DB32DQ42772455-2CEA02E1-D360-496A-96D9-762E5D550484Q46750707-909AAA96-A243-4BC1-95EB-302D2536CBACQ52574669-73660C12-C733-438A-AF34-51DB7FBC4547Q53395891-8AE4025F-C816-4819-9F0C-AC160F527056Q53792671-093BFD0B-AB89-4362-8650-9FA98CC31C9F
P2860
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@ast
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@en
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@nl
type
label
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@ast
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@en
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@nl
prefLabel
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@ast
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@en
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@nl
P2093
P356
P1476
Impact of single-residue mutat ...... ispirin antimicrobial peptides
@en
P2093
Alan J Waring
Brian F Tack
Monali V Sawai
Robert I Lehrer
William R Forsyth
William R Kearney
P304
P356
10.1093/PROTEIN/15.3.225
P577
2002-03-01T00:00:00Z